Cristina Cadoni
Maria Antonietta De Luca- 1CNR Institute of Neuroscience, Cagliari Section, National Research Council of Italy, Cagliari, Italy
- 2Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
Editorial on the Research Topic
Deconstructing the Influence of Genetic and Age Vulnerability to Psychiatric Disorders
The long-standing issue whether human behavior is more influenced by genes or by environment (nature vs. nurture) has characterized the scientific and social debates in particular in the twentieth century. Decades of genetic studies have highlighted the important contribution of genes in shaping “normal” and pathological phenotypes, but also have evidenced how genes interact with environment thus rendering the study of the genetic and environmental contribution more complex (1, 2). Nowadays we know that environment impacts on genes through epigenetic mechanisms, affecting gene regulation and expression without alteration in DNA sequence (3, 4). Therefore, development of psychopathologies is the result of a complex dynamic interplay between genetic and environmental factors where epigenetic alteration are the biological responses to environmental input and these epigenetic alterations can be transmitted to next generations as in the case of early trauma.
In this already complex picture another factor influencing behavioral phenotype, and thus the emergence of psychopathologies, is the age of the individual. Indeed, the entire developmental period, prenatal and early postnatal, is critical for gene x environment interaction, and events occurring during these periods might have long-lasting and powerful impacts also on next generations as it was recognized long time ago (5, 6). In this regard adolescence, the transition phase between childhood and adulthood, represents a particular critical one (7). In this developmental period an extensive neuroanatomical and functional reorganization occurs in the brain leading to substantial maturational changes in cognition and affect regulation. Thus adolescence is characterized by a heightened emotional reactivity, sensation and novelty seeking, risk taking behavior, sensitivity to peer influence, and impulsivity accompanied by a poor capacity to self-control on actions and emotions. Genetic influences on behavioral phenotypes also change (increase) during adolescence, highlighting the dynamic nature of genes impact on human behavior (8).
Adolescence is also a peak time for clinical onset of most mental illnesses, as well as substance use disorders (9, 10). This is likely due to a developmental mismatch between early maturing (limbic areas) and late maturing (cortical areas) brain structures responsible for typical adolescent behavior and predisposing to onset of psychopathologies (11, 12). Moreover, adolescence is also a time of high stress reactivity and stress response systems (hypothalamic-pituitary-adrenal axis) still maturing (13). All these factors (genetic, environmental, and epigenetic factors), that contribute to shape the brain, could be the reasons why some, but not all, adolescents are at higher risk to develop psychopathological disorders.
The authors of this research topic contributed to clarify the role of genetic and/or environmental factors in increasing the risk for psychopathologies or substance use disorders. Cimino et al. investigates how DNA methylation at the dopamine transporter (DAT) promoter influences risk for psychopathology and the intergenerational transmission between parents and school-age youths. The study explores the correlation between DAT methylation and the presence of psychopathological symptoms in parents and maladaptive emotional-behavioral functioning in children. These results add further evidence about the contribution of genetic and environmental factors in predicting psychopathological symptoms within non-clinical populations.
The debate about the involvement of brain-derived neurotrophic factor (BDNF) in the pathophysiology of major depressive disorder (MDD) has been further analyzed by Kishi et al. who, reviewing several meta-analysis, came to the conclusion that Val66Met polymorphism in the BDNF gene was not associated with MDD but appeared to be related to antidepressant response in patients with MDD. However plasma/serum BDNF levels were lower in patients with acute MDD and antidepressant and electroconvulsive therapy increased plasma/serum BDNF levels. Although Val66Met variation in the BDNF gene does not appear to be a risk factor for MDD, peripheral BDNF levels have been confirmed to be markers for the state of MDD.
One of the most common neurodevelopmental disorders in childhood is attention-deficit hyperactivity disorder (ADHD), characterized by inattention, impulsivity, and hyperactivity (14). The dopaminergic system has been shown to have a role in the etiology of this disorder (15). Although social impairment has not been considered a core feature of this disease, it has been frequently found in ADHD patients (16, 17) having serious implications in everyday life. There is evidence that impairment in social behavior is partly determined by genetic factors. Among these the gene catechol O-methyltransferase (COMT), coding for the enzyme degrading catecholaminergic neurotransmitters, has been implicated, and among the several polymorphisms found for this gene the Val158Met polymorphism has been associated with hyperactivity and inattention symptoms observed in ADHD patients. However, contrasting results appeared in the literature with some supporting a significant effect of the Val allele (18) in children with ADHD while others finding an effect of the Met allele (19). In their article Millenet et al. further analyzed the effects of the COMT gene Val158Met polymorphism on the degree of ADHD symptoms and on social behavior in a large epidemiological population of adolescents with the belief that investigation of gene-phenotype interactions could help in identifying vulnerable phenotypes for ADHD symptomatology.
Alterations in dopamine neurotransmission are not only associated with ADHD but also with obsessive-compulsive disorders (OCD), often associated with ADHD (20). These diseases are characterized by poor decision making and lack of control on executive functions. The underlying neurobiological mechanism of these disorders have been studied through the years by using many animal models. In this Topic Cinque et al. provide a first phenotypic characterization of DAT knockout rats as a promising model for studying ADHD, OCD, and other neuropsychiatric disorders such as compulsive behavioral addictions.
Preclinical research has given an extremely important contribution in disentangling the complex interplay between genes and environment and their contribution to psychopathologies. As regards the risk to develop psychiatric diseases following adolescent cannabis use, several preclinical investigations have provided evidence for a critical role of a reduced prefrontal cortical GABAergic neurotransmission (reviewed by Renard et al.) which seems to be at the basis of behavioral disturbances induced by repeated adolescent use of cannabis products. These results are consistent with a prefrontal GABAergic hypofunction in schizophrenic patients (21–25).
Alcohol Use Disorders (AUD) often originates during adolescence and young adulthood. Clinical studies suggest that early onset of alcohol use is associated with the risk to develop an AUD later in life (26–28). However results from animal studies have been contrasting. Therefore this issue has been further investigated by Labots et al. with the aim of comparing the influence of age of onset of alcohol consumption on control over alcohol seeking in rats.
Author Contributions
CC wrote the article. MADL critically revised and approved the final version of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
Topic Editors wish to thank all the authors contributing to this research topic, adding a piece to the puzzle of the complex interplay between genes and environmental factors in the etiology of psychiatric and substance use disorders. Our hearthfelt thanks go to the reviewers who found time in their busy schedules to revise the articles providing useful and constructive comments.
References
1. Tsuang MT, Bar JL, Stone WS, Faraone SV. Gene-environment interactions in mental disorders. World Psychiatry (2004) 3:73–83.
2. Kendler KS. What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol Psychiatry (2013) 18:1058–66. doi: 10.1038/mp.2013.50
3. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. (2003) 33(Suppl.):245–54. doi: 10.1038/ng1089
4. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature (2010) 465:721–7. doi: 10.1038/nature09230
6. Denenberg VH. The developmental sciences: state and fate of research funding. Science (1970) 170:763.
7. Keshavan MS, Giedd J, Lau JY, Lewis DA, Paus T. Changes in the adolescent brain and the pathophysiology of psychotic disorders. Lancet Psychiatry (2014) 1:549–58. doi: 10.1016/S2215-0366(14)00081-9
8. Dick DM, Adkins AE, Kuo SI. Genetic influences on adolescent behavior. Neurosci Biobehav Rev. (2016) 70:198–205. doi: 10.1016/j.neubiorev.2016.07.007
9. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 62:593–602. doi: 10.1001/archpsyc.62.6.593
10. Lee FS, Heimer H, Giedd JN, Lein ES, Šestan N, Weinberger DR, et al. Mental health. Adolescent mental health–opportunity and obligation. Science (2014) 346:547–9. doi: 10.1126/science.1260497
11. Brenhouse HC, Andersen SL. Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. Neurosci Biobehav Rev. (2011) 35:1687–703. doi: 10.1016/j.neubiorev.2011.04.013
12. Lenroot RK, Giedd JN. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci Biobehav Rev. (2006) 30:718–29. doi: 10.1016/j.neubiorev.2006.06.001
13. Romeo RD, McEwen BS. Stress and the adolescent brain. Ann N Y Acad Sci. (2006) 1094:202–14. doi: 10.1196/annals.1376.022
14. American Psychiatry Association (APA). Diagnostic and Statistical Manual of Mental Disorders DSM-5. 5th ed. Arlington, VA: American Psychiatric Association (2013). doi: 10.1176/appi.books.9780890425596
15. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. (2007) 17:39–59. doi: 10.1007/s11065-007-9019-9
16. Hoza B. Peer functioning in children with ADHD. J Pediatr Psychol. (2007) 32:655–63. doi: 10.1093/jpepsy/jsm024
17. Bunford N, Evans SW, Becker SP, Langberg JM. Attention-deficit/hyperactivity disorder and social skills in youth: a moderated mediation model of emotion dysregulation and depression. J Abnorm Child Psychol. (2015) 43:283–96. doi: 10.1007/s10802-014-9909-2
18. Akutagava-Martins GC, Rohde LA, Hutz MH. Genetics of attention-deficit/hyperactivity disorder: an update. Expert Rev Neurother. (2016) 16:145–56. doi: 10.1586/14737175.2016.1130626
19. Qian Q, Wang Y, Zhou R, Li J, Wang B, Glatt S, et al. Family-based and case-control association studies of catechol-O-methyltransferase in attention deficit hyperactivity disorder suggest genetic sexual dimorphism. Am J Med Genet B Neuropsychiatr Genet. (2003) 118B:103–9. doi: 10.1002/ajmg.b.10064
20. Abramovitch A, Dar R, Mittelman A, Wilhelm S. Comorbidity between attention deficit/hyperactivity disorder and obsessive-compulsive disorder across the lifespan: a systematic and critical review. Harv Rev Psychiatry (2015) 23:245–62. doi: 10.1097/HRP.0000000000000050
21. Curley AA, Arion D, Volk DW, Asafu-Adjei JK, Sampson AR, Fish KN, et al. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry (2011) 168:921–9. doi: 10.1176/appi.ajp.2011.11010052
22. Hashimoto T, Volk DW, Eggan SM, Mirnics K, Pierri JN, Sun Z, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. (2003) 23:6315–26. doi: 10.1523/JNEUROSCI.23-15-06315.2003
23. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry (2000) 57:237–45. doi: 10.1001/archpsyc.57.3.237
24. Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry (2000) 57:1061–9. doi: 10.1001/archpsyc.57.11.1061
25. Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Mayhew MB, et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry (2007) 12:854–69. doi: 10.1038/sj.mp.4001988
26. Grant BF, Dawson DA. Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse (1997) 9:103–10. doi: 10.1016/S0899-3289(97)90009-2
27. Dawson DA, Goldstein RB, Chou SP, Ruan WJ, Grant BF. Age at first drink and the first incidence of adult-onset DSM-IV alcohol use disorders. Alcohol Clin Exp Res. (2008) 32:2149–60. doi: 10.1111/j.1530-0277.2008.00806.x
Keywords: adolescence, genetic influence, environmental influence, epigenetics, THC - tetrahydrocannabinol, alcohol, substance use disorders (SUD), psychopathologies
Citation: Cadoni C and De Luca MA (2019) Editorial: Deconstructing the Influence of Genetic and Age Vulnerability to Psychiatric Disorders. Front. Psychiatry 10:13. doi: 10.3389/fpsyt.2019.00013
Received: 30 November 2018; Accepted: 10 January 2019;
Published: 25 January 2019.
Edited and reviewed by: David Cohen, Université Pierre et Marie Curie, France
Copyright © 2019 Cadoni and De Luca. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cristina Cadoni, Y2NhZG9uaUB1bmljYS5pdA==; Y3Jpc3RpbmEuY2Fkb25pQGluLmNuci5pdA==